Loading...
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine
AIM: In cancer immunotherapy, biomarkers are important for identification of responsive patients. This study was aimed to find biomarkers that predict clinical outcome of WT1 peptide vaccination. MATERIALS & METHODS: Candidate genes that were expressed differentially between long- and short-term...
Na minha lista:
| Udgivet i: | Future Sci OA |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Science Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241910/ https://ncbi.nlm.nih.gov/pubmed/28116121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fsoa-2015-0008 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|